封面
市场调查报告书
商品编码
1649515

动脉粥状硬化斑块切除术设备市场:预测(2025-2030 年)

Atherectomy Devices Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计动脉粥状硬化斑块切除术设备市场规模将从 2025 年的 11,860.3 亿美元成长到 2030 年的 16,860.32 亿美元,复合年增长率为 7.29%。

动脉粥状硬化斑块切除术装置旨在去除动脉粥状硬化血管中的斑块和其他物质。动脉粥状硬化斑块切除术有不同的类型,包括切除动脉粥状硬化斑块切除术、雷射消熔动脉粥状硬化斑块切除术和旋转动脉粥状硬化斑块切除术。全球动脉粥状硬化斑块切除术设备市场正在经历显着成长,这主要得益于医疗技术的快速进步。最近的趋势导致采用更安全、更有效率的设备,这有助于市场的扩大。这一增长的主要驱动力是对微创手术的需求不断增长。目前,人们明显倾向于微创手术,其优点包括恢復时间更快、併发症发生率更低。然而,设备和程序的高成本仍然是市场成长的障碍。这些设备的开发需要大量的研究经费,这也是製造成本增加的原因之一。此外,儘管动脉粥状硬化斑块切除术装置有助于扩张动脉,但也可能导致血管再阻塞率增加,这可能会影响长期结果。

动脉粥状硬化斑块切除术设备市场驱动因素

  • 心血管疾病盛行率上升:全球心血管疾病盛行率上升是推动动脉粥状硬化动脉粥状硬化斑块切除术设备市场成长的关键因素。随着周边动脉疾病(PAD) 和冠状动脉疾病 (CAD) 等疾病变得越来越常见,动脉粥状硬化斑块切除术设备对于恢復健康血流和缓解与这些疾病相关的症状至关重要。根据美国心臟协会统计,週边动脉疾病影响全球约 2 亿人,光是美国就报告了约 1,200 万例。在70岁以上的族群中,週边动脉疾病的发生率尤其高。

地理视角

  • 预计北美将占据主导地位:预计在预测期内,北美将占据动脉粥状硬化斑块切除术设备市场的大部分份额。由于心血管疾病发病率不断上升,该地区正在经历强劲增长,尤其是在美国和加拿大。此外,医疗保健领域的进步也促进了市场的扩张。优惠的报销政策和强大的医疗保健基础设施进一步支持了北美心血管疾病盛行率的不断上升。

总之,心血管疾病盛行率不断上升和技术进步等因素预计将推动动脉粥状硬化斑块切除术设备市场的成长,尤其是在北美。

为什么要购买这份报告?

  • 深刻分析:获得深入的市场洞察,涵盖主要和新兴地区,重点关注客户群、政府政策和社会经济因素、消费者偏好、垂直行业和其他子区隔。
  • 竞争格局:了解全球主要企业所采用的策略策略,并了解正确策略带来的潜在市场渗透率。
  • 市场趋势和驱动因素:探索动态因素和关键市场趋势以及它们将如何影响未来的市场发展。
  • 可行的建议:利用洞察力做出策略决策,在动态环境中开闢新的业务流和收益。
  • 受众广泛:对于新兴企业、研究机构、顾问公司、中小企业和大型企业都有益且具有成本效益。

它有什么用途?

产业与市场分析、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本支出决策、法律规范与影响、新产品开发、竞争影响

研究范围

  • 2022 年至 2030 年的实际资料和预测
  • 成长机会、挑战、供应链前景、法规结构、顾客行为、趋势分析
  • 竞争定位、策略与市场占有率分析
  • 细分和区域分析,包括收益成长和预测国家
  • 公司概况(策略、产品、财务、主要发展等)

动脉粥状硬化斑块切除术设备市场细分与分析如下:

依产品类型

  • 定向动脉粥状硬化斑块切除术装置
  • 旋动脉粥状硬化斑块切除术装置
  • 眼眶动脉粥状硬化斑块切除术装置
  • 雷射动脉粥状硬化斑块切除术装置
  • 光消融动脉粥状硬化斑块切除术装置
  • 其他的

按应用

  • 周围血管
  • 心血管
  • 神经血管

按最终用户

  • 医院
  • 研究所
  • 门诊手术中心
  • 其他的

按地区

  • 北美洲
  • 美国
  • 加拿大
  • 墨西哥
  • 南美洲
  • 巴西
  • 阿根廷
  • 其他的
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
  • 中东和非洲
  • 沙乌地阿拉伯
  • UAE
  • 以色列
  • 其他的
  • 亚太地区
  • 日本
  • 中国
  • 印度
  • 韩国
  • 印尼
  • 泰国
  • 台湾
  • 其他的

目录

第 1 章 简介

  • 市场概况
  • 市场定义
  • 研究范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关人员的主要利益

第二章调查方法

  • 研究设计
  • 研究过程

第三章执行摘要

  • 主要发现

第四章 市场动态

  • 市场驱动因素
  • 市场限制
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第 5 章动脉粥状硬化斑块切除术设备市场(依产品类型)

  • 介绍
  • 定向动脉粥状硬化斑块切除术装置
  • 旋动脉粥状硬化斑块切除术装置
  • 眼眶动脉粥状硬化斑块切除术装置
  • 雷射动脉粥状硬化斑块切除术装置
  • 光消融动脉粥状硬化斑块切除术状硬化切除装置
  • 其他的

第六章动脉粥状硬化斑块切除术设备市场(依应用)

  • 介绍
  • 周围血管
  • 心血管
  • 神经血管

第 7 章动脉粥状硬化斑块切除术设备市场(依最终用户划分)

  • 介绍
  • 医院
  • 研究所
  • 门诊手术中心
  • 其他的

第 8 章动脉粥状硬化斑块切除术设备市场(按地区)

  • 介绍
  • 北美洲
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家
  • 南美洲
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家
  • 欧洲
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家
  • 中东和非洲
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家
  • 亚太地区
    • 依产品类型
    • 按应用
    • 按最终用户
    • 按国家

第九章竞争格局及分析

  • 主要企业和策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争仪錶板

第十章 公司简介

  • Boston Scientific Corporation
  • BD(Becton, Dickinson, and Company)
  • Abbott
  • Koninklijke Philips NV
  • Medtronic
  • AngioDynamics
  • Biomerics
  • Avinger
  • Cardio Flow, Inc.
  • InspireMD, Inc
  • AMETEK Inc.
简介目录
Product Code: KSI061617279

The atherectomy devices market is estimated to grow from US$1,186.030 million in 2025 to US$1,686.032 million by 2030, at a CAGR of 7.29%.

An atherectomy device is designed to remove plaque and other materials from atherosclerotic blood vessels. Various types of atherectomy procedures exist, including excisional atherectomy, laser ablation atherectomy, and rotational atherectomy. The global atherectomy device market is experiencing significant growth, primarily due to rapid advancements in medical technology. Recent developments have led to the introduction of safer and more efficient devices, which have contributed to the market's expansion.A key driver of this growth is the increasing demand for minimally invasive procedures. There has been a notable shift towards less invasive surgeries, which offer benefits such as reduced recovery times and lower complication rates. However, the high cost of equipment and procedures poses a challenge to market growth. Developing these devices involves substantial research expenses, which contribute to rising manufacturing costs. Additionally, while atherectomy devices can help dilate arteries, they may also lead to increased rates of restenosis, potentially affecting their long-term effectiveness.

Drivers of the Atherectomy Devices Market

  • Rising Prevalence of Cardiovascular Diseases: The increasing incidence of cardiovascular diseases globally is a significant factor driving the growth of the atherectomy device market. Conditions such as Peripheral Artery Disease (PAD) and Coronary Artery Disease (CAD) are becoming more common, and atherectomy devices are essential for restoring healthy blood flow and alleviating symptoms associated with these diseases. According to the American Heart Association, approximately 200 million people worldwide are affected by PAD, with around 12 million cases reported in the USA alone. The prevalence of PAD is particularly high among individuals over 70 years old.

Geographical Outlook

  • North America Expected to Dominate: North America is projected to hold a substantial share of the atherectomy devices market during the forecast period. The region is witnessing significant growth due to the rising cases of cardiovascular diseases, especially in the USA and Canada. Additionally, advancements in the healthcare sector are contributing to market expansion. The increasing prevalence of cardiovascular conditions in North America is further supported by favorable reimbursement policies and a robust healthcare infrastructure.

In summary, factors such as the growing prevalence of cardiovascular diseases and technological advancements are expected to drive growth in the atherectomy device market, particularly in North America.

Reasons for buying this report:-

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, other sub- segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape up future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decision to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data & forecasts from 2022 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, Customer Behaviour, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others)

The Atherectomy Devices Market is segmented and analyzed as:

By Product Type

  • Directional Atherectomy Devices
  • Rotational Atherectomy Devices
  • Orbital Atherectomy Devices
  • Laser Atherectomy Devices
  • Photo-Ablative Atherectomy Devices
  • Others

By Application

  • Peripheral Vascular
  • Cardiovascular
  • Neurovascular

By End-User

  • Hospitals
  • Research Laboratories
  • Ambulatory Surgical Centers
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Others
  • Asia Pacific Region
  • Japan
  • China
  • India
  • South Korea
  • Indonesia
  • Thailand
  • Taiwan
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key benefits for the stakeholders

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Process

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. The Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. ATHERECTOMY DEVICES MARKET BY PRODUCT TYPE

  • 5.1. Introduction
  • 5.2. Directional Atherectomy Devices
  • 5.3. Rotational Atherectomy Devices
  • 5.4. Orbital Atherectomy Devices
  • 5.5. Laser Atherectomy Devices
  • 5.6. Photo-Ablative Atherectomy Devices
  • 5.7. Others

6. ATHERECTOMY DEVICES MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. Peripheral Vascular
  • 6.3. Cardiovascular
  • 6.4. Neurovascular

7. ATHERECTOMY DEVICES MARKET BY END-USER

  • 7.1. Introduction
  • 7.2. Hospitals
  • 7.3. Research Laboratories
  • 7.4. Ambulatory Surgical Centers
  • 7.5. Others

8. ATHERECTOMY DEVICES MARKET BY GEOGRAPHY

  • 8.1. Introduction
  • 8.2. North America
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By End-User
    • 8.2.4. By Country
      • 8.2.4.1. United States
      • 8.2.4.2. Canada
      • 8.2.4.3. Mexico
  • 8.3. South America
    • 8.3.1. By Product Type
    • 8.3.2. By Application
    • 8.3.3. By End-User
    • 8.3.4. By Country
      • 8.3.4.1. Brazil
      • 8.3.4.2. Argentina
      • 8.3.4.3. Others
  • 8.4. Europe
    • 8.4.1. By Product Type
    • 8.4.2. By Application
    • 8.4.3. By End-User
    • 8.4.4. By Country
      • 8.4.4.1. Germany
      • 8.4.4.2. France
      • 8.4.4.3. United Kingdom
      • 8.4.4.4. Spain
      • 8.4.4.5. Others
  • 8.5. Middle East and Africa
    • 8.5.1. By Product Type
    • 8.5.2. By Application
    • 8.5.3. By End-User
    • 8.5.4. By Country
      • 8.5.4.1. UAE
      • 8.5.4.2. Saudi Arabia
      • 8.5.4.3. Others
  • 8.6. Asia Pacific
    • 8.6.1. By Product Type
    • 8.6.2. By Application
    • 8.6.3. By End-User
    • 8.6.4. By Country
      • 8.6.4.1. Japan
      • 8.6.4.2. China
      • 8.6.4.3. India
      • 8.6.4.4. South Korea
      • 8.6.4.5. Indonesia
      • 8.6.4.6. Thailand
      • 8.6.4.7. Taiwan
      • 8.6.4.8. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 9.1. Major Players and Strategy Analysis
  • 9.2. Market Share Analysis
  • 9.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 9.4. Competitive Dashboard

10. COMPANY PROFILES

  • 10.1. Boston Scientific Corporation
  • 10.2. BD (Becton, Dickinson, and Company)
  • 10.3. Abbott
  • 10.4. Koninklijke Philips N.V.
  • 10.5. Medtronic
  • 10.6. AngioDynamics
  • 10.7. Biomerics
  • 10.8. Avinger
  • 10.9. Cardio Flow, Inc.
  • 10.10. InspireMD, Inc
  • 10.11. AMETEK Inc.